In focus · trending topic

Phase 2b results

2 stories · following the connections

Galectin Therapeutics Announces Results from Phase 2b NASH-CX Trial

By Nasdaq OMXDec 5, 2017, 1:15 PM UTC

Galectin Therapeutics to Present Results from Phase 2b NASH-CX Trial on December 5, 2017

By Nasdaq OMXDec 4, 2017, 9:00 PM UTC